HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, R B Articles by Haskell, W L Search for Related Content PubMed PubMed Citation Articles by Harris, R B Articles by Haskell, W L

Are women using postmenopausal estrogens? A community survey.

R B Harris, A Laws, V M Reddy, A King and W L Haskell

Stanford Center for Research in Disease Prevention, Stanford University, CA.

Self-reported estrogen and progestin use in a California community was determined in 1986-87 from a telephone survey of postmenopausal women (n = 954) ages 50-65 years. Current use of hormones was reported by 32 percent; 26 percent took estrogens alone while 6 percent used estrogen + progestin. Comparisons pointed to significant social network and medical care utilization differences. Women who used estrogen therapy were younger, thinner, lived in smaller household units, and were less likely to be widowed.

This article has been cited by other articles:

				M. R. McClung, R. D. Wasnich, D. J. Hosking, C. Christiansen, P. Ravn, M. Wu, A. M. Mantz, J. Yates, P. D. Ross, A. C. Santora II, et al. Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4879 - 4885. [Abstract] [Full Text] [PDF]

				L. K. Weiss, R. T. Burkman, K. L. Cushing-Haugen, L. F. Voigt, M. S. Simon, J. R. Daling, S. A. Norman, L. Bernstein, G. Ursin, P. A. Marchbanks, et al. Hormone Replacement Therapy Regimens and Breast Cancer Risk Obstet. Gynecol., December 1, 2002; 100(6): 1148 - 1158. [Abstract] [Full Text] [PDF]

				X. L. Ma, F. Gao, J. Chen, T. A. Christopher, B. L. Lopez, E. H. Ohlstein, and T.-L. Yue Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H876 - H884. [Abstract] [Full Text] [PDF]

				X. L. Ma, F. Gao, C.-L. Yao, J. Chen, B. L. Lopez, T. A. Christopher, J. Disa, J.-L. Gu, E. H. Ohlstein, and T.-L. Yue Nitric Oxide Stimulatory and Endothelial Protective Effects of Idoxifene, a Selective Estrogen Receptor Modulator, in the Splanchnic Artery of the Ovariectomized Rat J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 786 - 792. [Abstract] [Full Text]

				G. A. Figtree, Y.-q. Lu, C. M. Webb, and P. Collins Raloxifene Acutely Relaxes Rabbit Coronary Arteries In Vitro by an Estrogen Receptor–Dependent and Nitric Oxide–Dependent Mechanism Circulation, September 7, 1999; 100(10): 1095 - 1101. [Abstract] [Full Text] [PDF]

				H. M. Perry III The Endocrinology of Aging Clin. Chem., August 1, 1999; 45(8): 1369 - 1376. [Abstract] [Full Text] [PDF]

				N. L. Keating, P. D. Cleary, A. S. Rossi, A. M. Zaslavsky, and J. Z. Ayanian Use of Hormone Replacement Therapy by Postmenopausal Women in the United States Ann Intern Med, April 6, 1999; 130(7): 545 - 553. [Abstract] [Full Text] [PDF]

				E. Hemminki and K. McPherson Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials BMJ, July 19, 1997; 315(7101): 149 - 153. [Abstract] [Full Text]

				Y. Zhang, D. P. Kiel, B. E. Kreger, L. A. Cupples, R. C. Ellison, J. F. Dorgan, A. Schatzkin, D. Levy, and D. T. Felson Bone Mass and the Risk of Breast Cancer among Postmenopausal Women N. Engl. J. Med., February 27, 1997; 336(9): 611 - 617. [Abstract] [Full Text] [PDF]

				A J Isaacs, A R Britton, and K. McPherson Utilisation of hormone replacement therapy by women doctors BMJ, November 25, 1995; 311(7017): 1399 - 1401. [Abstract] [Full Text]